
|Articles|February 15, 2004
In-office test found useful adjunct to cystoscopy
Las Vegas--An in-office bladder cancer test is significantly more sensitive than cytology at detecting the disease in high-risk patients, report community-based urologists from Anchorage, AK. The test also appears to be effective at determining risk of recurrence in patients with known disease, at least in the short term.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
2
Farah Rahman, MD, on monitoring resident wellness using biofeedback
3
Veda Giri, MD, on patient-reported outcomes with prostate cancer genetic testing
4
Pearls & Perspectives: Innovation and Evolving Pathways in Female Pelvic Medicine, with Raveen Syan, MD, FPMRS
5






